Scalper1 News
AstraZeneca on Monday rejected Pfizer’s “final proposal” buyout offer of $117 billion. Shares of the British drug giant dived as investors seemed to lose hope that the merger of titans would ever take place. Pfizer (PFE) first revealed on April 28 that AstraZeneca (AZN) had rejected a proposal early this year, and a few days later made a higher bid of 50 British pounds per share, or about $106 billion. AstraZeneca turned Pfizer down Scalper1 News
Scalper1 News